Medical Care
Global AI-driven Drug Discovery Market Research Report 2025
- May 05, 25
- ID: 226214
- Pages: 91
- Figures: 92
- Views: 49
The global market for AI-driven Drug Discovery was valued at US$ 825 million in the year 2024 and is projected to reach a revised size of US$ 1644 million by 2031, growing at a CAGR of 10.5% during the forecast period.
AI, its end-to-end drug discovery platform using generative artificial intelligence to discover new targets, design new molecules, and predict the outcome of clinical trials.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for AI-driven Drug Discovery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI-driven Drug Discovery.
The AI-driven Drug Discovery market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global AI-driven Drug Discovery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the AI-driven Drug Discovery companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Entos
Selvita
Benevolent
Exscientia
Euretos
Illumina with AstraZeneca
Novo Nordisk with Microsoft
Iktos
Aqemia
Zephyr AI
Cyclicarx
Eli Lilly
Terray Therapeutics
Ardigen
ReviveMed
Insilico Medicine
XtalPi
MindRank
DP Technology
Segment by Type
Small Molecule Drug
Biological Modeling
Structural Biology
Others
Segment by Application
Pharmaceutical and Biotechnology Companies
Research Laboratories
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of AI-driven Drug Discovery company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
AI, its end-to-end drug discovery platform using generative artificial intelligence to discover new targets, design new molecules, and predict the outcome of clinical trials.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for AI-driven Drug Discovery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI-driven Drug Discovery.
The AI-driven Drug Discovery market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global AI-driven Drug Discovery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the AI-driven Drug Discovery companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Entos
Selvita
Benevolent
Exscientia
Euretos
Illumina with AstraZeneca
Novo Nordisk with Microsoft
Iktos
Aqemia
Zephyr AI
Cyclicarx
Eli Lilly
Terray Therapeutics
Ardigen
ReviveMed
Insilico Medicine
XtalPi
MindRank
DP Technology
Segment by Type
Small Molecule Drug
Biological Modeling
Structural Biology
Others
Segment by Application
Pharmaceutical and Biotechnology Companies
Research Laboratories
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of AI-driven Drug Discovery company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AI-driven Drug Discovery Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Small Molecule Drug
1.2.3 Biological Modeling
1.2.4 Structural Biology
1.2.5 Others
1.3 Market by Application
1.3.1 Global AI-driven Drug Discovery Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical and Biotechnology Companies
1.3.3 Research Laboratories
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global AI-driven Drug Discovery Market Perspective (2020-2031)
2.2 Global AI-driven Drug Discovery Growth Trends by Region
2.2.1 Global AI-driven Drug Discovery Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 AI-driven Drug Discovery Historic Market Size by Region (2020-2025)
2.2.3 AI-driven Drug Discovery Forecasted Market Size by Region (2026-2031)
2.3 AI-driven Drug Discovery Market Dynamics
2.3.1 AI-driven Drug Discovery Industry Trends
2.3.2 AI-driven Drug Discovery Market Drivers
2.3.3 AI-driven Drug Discovery Market Challenges
2.3.4 AI-driven Drug Discovery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top AI-driven Drug Discovery Players by Revenue
3.1.1 Global Top AI-driven Drug Discovery Players by Revenue (2020-2025)
3.1.2 Global AI-driven Drug Discovery Revenue Market Share by Players (2020-2025)
3.2 Global AI-driven Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by AI-driven Drug Discovery Revenue
3.4 Global AI-driven Drug Discovery Market Concentration Ratio
3.4.1 Global AI-driven Drug Discovery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AI-driven Drug Discovery Revenue in 2024
3.5 Global Key Players of AI-driven Drug Discovery Head office and Area Served
3.6 Global Key Players of AI-driven Drug Discovery, Product and Application
3.7 Global Key Players of AI-driven Drug Discovery, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 AI-driven Drug Discovery Breakdown Data by Type
4.1 Global AI-driven Drug Discovery Historic Market Size by Type (2020-2025)
4.2 Global AI-driven Drug Discovery Forecasted Market Size by Type (2026-2031)
5 AI-driven Drug Discovery Breakdown Data by Application
5.1 Global AI-driven Drug Discovery Historic Market Size by Application (2020-2025)
5.2 Global AI-driven Drug Discovery Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America AI-driven Drug Discovery Market Size (2020-2031)
6.2 North America AI-driven Drug Discovery Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America AI-driven Drug Discovery Market Size by Country (2020-2025)
6.4 North America AI-driven Drug Discovery Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe AI-driven Drug Discovery Market Size (2020-2031)
7.2 Europe AI-driven Drug Discovery Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe AI-driven Drug Discovery Market Size by Country (2020-2025)
7.4 Europe AI-driven Drug Discovery Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific AI-driven Drug Discovery Market Size (2020-2031)
8.2 Asia-Pacific AI-driven Drug Discovery Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific AI-driven Drug Discovery Market Size by Region (2020-2025)
8.4 Asia-Pacific AI-driven Drug Discovery Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America AI-driven Drug Discovery Market Size (2020-2031)
9.2 Latin America AI-driven Drug Discovery Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America AI-driven Drug Discovery Market Size by Country (2020-2025)
9.4 Latin America AI-driven Drug Discovery Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AI-driven Drug Discovery Market Size (2020-2031)
10.2 Middle East & Africa AI-driven Drug Discovery Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa AI-driven Drug Discovery Market Size by Country (2020-2025)
10.4 Middle East & Africa AI-driven Drug Discovery Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Entos
11.1.1 Entos Company Details
11.1.2 Entos Business Overview
11.1.3 Entos AI-driven Drug Discovery Introduction
11.1.4 Entos Revenue in AI-driven Drug Discovery Business (2020-2025)
11.1.5 Entos Recent Development
11.2 Selvita
11.2.1 Selvita Company Details
11.2.2 Selvita Business Overview
11.2.3 Selvita AI-driven Drug Discovery Introduction
11.2.4 Selvita Revenue in AI-driven Drug Discovery Business (2020-2025)
11.2.5 Selvita Recent Development
11.3 Benevolent
11.3.1 Benevolent Company Details
11.3.2 Benevolent Business Overview
11.3.3 Benevolent AI-driven Drug Discovery Introduction
11.3.4 Benevolent Revenue in AI-driven Drug Discovery Business (2020-2025)
11.3.5 Benevolent Recent Development
11.4 Exscientia
11.4.1 Exscientia Company Details
11.4.2 Exscientia Business Overview
11.4.3 Exscientia AI-driven Drug Discovery Introduction
11.4.4 Exscientia Revenue in AI-driven Drug Discovery Business (2020-2025)
11.4.5 Exscientia Recent Development
11.5 Euretos
11.5.1 Euretos Company Details
11.5.2 Euretos Business Overview
11.5.3 Euretos AI-driven Drug Discovery Introduction
11.5.4 Euretos Revenue in AI-driven Drug Discovery Business (2020-2025)
11.5.5 Euretos Recent Development
11.6 Illumina with AstraZeneca
11.6.1 Illumina with AstraZeneca Company Details
11.6.2 Illumina with AstraZeneca Business Overview
11.6.3 Illumina with AstraZeneca AI-driven Drug Discovery Introduction
11.6.4 Illumina with AstraZeneca Revenue in AI-driven Drug Discovery Business (2020-2025)
11.6.5 Illumina with AstraZeneca Recent Development
11.7 Novo Nordisk with Microsoft
11.7.1 Novo Nordisk with Microsoft Company Details
11.7.2 Novo Nordisk with Microsoft Business Overview
11.7.3 Novo Nordisk with Microsoft AI-driven Drug Discovery Introduction
11.7.4 Novo Nordisk with Microsoft Revenue in AI-driven Drug Discovery Business (2020-2025)
11.7.5 Novo Nordisk with Microsoft Recent Development
11.8 Iktos
11.8.1 Iktos Company Details
11.8.2 Iktos Business Overview
11.8.3 Iktos AI-driven Drug Discovery Introduction
11.8.4 Iktos Revenue in AI-driven Drug Discovery Business (2020-2025)
11.8.5 Iktos Recent Development
11.9 Aqemia
11.9.1 Aqemia Company Details
11.9.2 Aqemia Business Overview
11.9.3 Aqemia AI-driven Drug Discovery Introduction
11.9.4 Aqemia Revenue in AI-driven Drug Discovery Business (2020-2025)
11.9.5 Aqemia Recent Development
11.10 Zephyr AI
11.10.1 Zephyr AI Company Details
11.10.2 Zephyr AI Business Overview
11.10.3 Zephyr AI AI-driven Drug Discovery Introduction
11.10.4 Zephyr AI Revenue in AI-driven Drug Discovery Business (2020-2025)
11.10.5 Zephyr AI Recent Development
11.11 Cyclicarx
11.11.1 Cyclicarx Company Details
11.11.2 Cyclicarx Business Overview
11.11.3 Cyclicarx AI-driven Drug Discovery Introduction
11.11.4 Cyclicarx Revenue in AI-driven Drug Discovery Business (2020-2025)
11.11.5 Cyclicarx Recent Development
11.12 Eli Lilly
11.12.1 Eli Lilly Company Details
11.12.2 Eli Lilly Business Overview
11.12.3 Eli Lilly AI-driven Drug Discovery Introduction
11.12.4 Eli Lilly Revenue in AI-driven Drug Discovery Business (2020-2025)
11.12.5 Eli Lilly Recent Development
11.13 Terray Therapeutics
11.13.1 Terray Therapeutics Company Details
11.13.2 Terray Therapeutics Business Overview
11.13.3 Terray Therapeutics AI-driven Drug Discovery Introduction
11.13.4 Terray Therapeutics Revenue in AI-driven Drug Discovery Business (2020-2025)
11.13.5 Terray Therapeutics Recent Development
11.14 Ardigen
11.14.1 Ardigen Company Details
11.14.2 Ardigen Business Overview
11.14.3 Ardigen AI-driven Drug Discovery Introduction
11.14.4 Ardigen Revenue in AI-driven Drug Discovery Business (2020-2025)
11.14.5 Ardigen Recent Development
11.15 ReviveMed
11.15.1 ReviveMed Company Details
11.15.2 ReviveMed Business Overview
11.15.3 ReviveMed AI-driven Drug Discovery Introduction
11.15.4 ReviveMed Revenue in AI-driven Drug Discovery Business (2020-2025)
11.15.5 ReviveMed Recent Development
11.16 Insilico Medicine
11.16.1 Insilico Medicine Company Details
11.16.2 Insilico Medicine Business Overview
11.16.3 Insilico Medicine AI-driven Drug Discovery Introduction
11.16.4 Insilico Medicine Revenue in AI-driven Drug Discovery Business (2020-2025)
11.16.5 Insilico Medicine Recent Development
11.17 XtalPi
11.17.1 XtalPi Company Details
11.17.2 XtalPi Business Overview
11.17.3 XtalPi AI-driven Drug Discovery Introduction
11.17.4 XtalPi Revenue in AI-driven Drug Discovery Business (2020-2025)
11.17.5 XtalPi Recent Development
11.18 MindRank
11.18.1 MindRank Company Details
11.18.2 MindRank Business Overview
11.18.3 MindRank AI-driven Drug Discovery Introduction
11.18.4 MindRank Revenue in AI-driven Drug Discovery Business (2020-2025)
11.18.5 MindRank Recent Development
11.19 DP Technology
11.19.1 DP Technology Company Details
11.19.2 DP Technology Business Overview
11.19.3 DP Technology AI-driven Drug Discovery Introduction
11.19.4 DP Technology Revenue in AI-driven Drug Discovery Business (2020-2025)
11.19.5 DP Technology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AI-driven Drug Discovery Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Small Molecule Drug
1.2.3 Biological Modeling
1.2.4 Structural Biology
1.2.5 Others
1.3 Market by Application
1.3.1 Global AI-driven Drug Discovery Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical and Biotechnology Companies
1.3.3 Research Laboratories
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global AI-driven Drug Discovery Market Perspective (2020-2031)
2.2 Global AI-driven Drug Discovery Growth Trends by Region
2.2.1 Global AI-driven Drug Discovery Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 AI-driven Drug Discovery Historic Market Size by Region (2020-2025)
2.2.3 AI-driven Drug Discovery Forecasted Market Size by Region (2026-2031)
2.3 AI-driven Drug Discovery Market Dynamics
2.3.1 AI-driven Drug Discovery Industry Trends
2.3.2 AI-driven Drug Discovery Market Drivers
2.3.3 AI-driven Drug Discovery Market Challenges
2.3.4 AI-driven Drug Discovery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top AI-driven Drug Discovery Players by Revenue
3.1.1 Global Top AI-driven Drug Discovery Players by Revenue (2020-2025)
3.1.2 Global AI-driven Drug Discovery Revenue Market Share by Players (2020-2025)
3.2 Global AI-driven Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by AI-driven Drug Discovery Revenue
3.4 Global AI-driven Drug Discovery Market Concentration Ratio
3.4.1 Global AI-driven Drug Discovery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AI-driven Drug Discovery Revenue in 2024
3.5 Global Key Players of AI-driven Drug Discovery Head office and Area Served
3.6 Global Key Players of AI-driven Drug Discovery, Product and Application
3.7 Global Key Players of AI-driven Drug Discovery, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 AI-driven Drug Discovery Breakdown Data by Type
4.1 Global AI-driven Drug Discovery Historic Market Size by Type (2020-2025)
4.2 Global AI-driven Drug Discovery Forecasted Market Size by Type (2026-2031)
5 AI-driven Drug Discovery Breakdown Data by Application
5.1 Global AI-driven Drug Discovery Historic Market Size by Application (2020-2025)
5.2 Global AI-driven Drug Discovery Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America AI-driven Drug Discovery Market Size (2020-2031)
6.2 North America AI-driven Drug Discovery Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America AI-driven Drug Discovery Market Size by Country (2020-2025)
6.4 North America AI-driven Drug Discovery Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe AI-driven Drug Discovery Market Size (2020-2031)
7.2 Europe AI-driven Drug Discovery Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe AI-driven Drug Discovery Market Size by Country (2020-2025)
7.4 Europe AI-driven Drug Discovery Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific AI-driven Drug Discovery Market Size (2020-2031)
8.2 Asia-Pacific AI-driven Drug Discovery Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific AI-driven Drug Discovery Market Size by Region (2020-2025)
8.4 Asia-Pacific AI-driven Drug Discovery Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America AI-driven Drug Discovery Market Size (2020-2031)
9.2 Latin America AI-driven Drug Discovery Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America AI-driven Drug Discovery Market Size by Country (2020-2025)
9.4 Latin America AI-driven Drug Discovery Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AI-driven Drug Discovery Market Size (2020-2031)
10.2 Middle East & Africa AI-driven Drug Discovery Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa AI-driven Drug Discovery Market Size by Country (2020-2025)
10.4 Middle East & Africa AI-driven Drug Discovery Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Entos
11.1.1 Entos Company Details
11.1.2 Entos Business Overview
11.1.3 Entos AI-driven Drug Discovery Introduction
11.1.4 Entos Revenue in AI-driven Drug Discovery Business (2020-2025)
11.1.5 Entos Recent Development
11.2 Selvita
11.2.1 Selvita Company Details
11.2.2 Selvita Business Overview
11.2.3 Selvita AI-driven Drug Discovery Introduction
11.2.4 Selvita Revenue in AI-driven Drug Discovery Business (2020-2025)
11.2.5 Selvita Recent Development
11.3 Benevolent
11.3.1 Benevolent Company Details
11.3.2 Benevolent Business Overview
11.3.3 Benevolent AI-driven Drug Discovery Introduction
11.3.4 Benevolent Revenue in AI-driven Drug Discovery Business (2020-2025)
11.3.5 Benevolent Recent Development
11.4 Exscientia
11.4.1 Exscientia Company Details
11.4.2 Exscientia Business Overview
11.4.3 Exscientia AI-driven Drug Discovery Introduction
11.4.4 Exscientia Revenue in AI-driven Drug Discovery Business (2020-2025)
11.4.5 Exscientia Recent Development
11.5 Euretos
11.5.1 Euretos Company Details
11.5.2 Euretos Business Overview
11.5.3 Euretos AI-driven Drug Discovery Introduction
11.5.4 Euretos Revenue in AI-driven Drug Discovery Business (2020-2025)
11.5.5 Euretos Recent Development
11.6 Illumina with AstraZeneca
11.6.1 Illumina with AstraZeneca Company Details
11.6.2 Illumina with AstraZeneca Business Overview
11.6.3 Illumina with AstraZeneca AI-driven Drug Discovery Introduction
11.6.4 Illumina with AstraZeneca Revenue in AI-driven Drug Discovery Business (2020-2025)
11.6.5 Illumina with AstraZeneca Recent Development
11.7 Novo Nordisk with Microsoft
11.7.1 Novo Nordisk with Microsoft Company Details
11.7.2 Novo Nordisk with Microsoft Business Overview
11.7.3 Novo Nordisk with Microsoft AI-driven Drug Discovery Introduction
11.7.4 Novo Nordisk with Microsoft Revenue in AI-driven Drug Discovery Business (2020-2025)
11.7.5 Novo Nordisk with Microsoft Recent Development
11.8 Iktos
11.8.1 Iktos Company Details
11.8.2 Iktos Business Overview
11.8.3 Iktos AI-driven Drug Discovery Introduction
11.8.4 Iktos Revenue in AI-driven Drug Discovery Business (2020-2025)
11.8.5 Iktos Recent Development
11.9 Aqemia
11.9.1 Aqemia Company Details
11.9.2 Aqemia Business Overview
11.9.3 Aqemia AI-driven Drug Discovery Introduction
11.9.4 Aqemia Revenue in AI-driven Drug Discovery Business (2020-2025)
11.9.5 Aqemia Recent Development
11.10 Zephyr AI
11.10.1 Zephyr AI Company Details
11.10.2 Zephyr AI Business Overview
11.10.3 Zephyr AI AI-driven Drug Discovery Introduction
11.10.4 Zephyr AI Revenue in AI-driven Drug Discovery Business (2020-2025)
11.10.5 Zephyr AI Recent Development
11.11 Cyclicarx
11.11.1 Cyclicarx Company Details
11.11.2 Cyclicarx Business Overview
11.11.3 Cyclicarx AI-driven Drug Discovery Introduction
11.11.4 Cyclicarx Revenue in AI-driven Drug Discovery Business (2020-2025)
11.11.5 Cyclicarx Recent Development
11.12 Eli Lilly
11.12.1 Eli Lilly Company Details
11.12.2 Eli Lilly Business Overview
11.12.3 Eli Lilly AI-driven Drug Discovery Introduction
11.12.4 Eli Lilly Revenue in AI-driven Drug Discovery Business (2020-2025)
11.12.5 Eli Lilly Recent Development
11.13 Terray Therapeutics
11.13.1 Terray Therapeutics Company Details
11.13.2 Terray Therapeutics Business Overview
11.13.3 Terray Therapeutics AI-driven Drug Discovery Introduction
11.13.4 Terray Therapeutics Revenue in AI-driven Drug Discovery Business (2020-2025)
11.13.5 Terray Therapeutics Recent Development
11.14 Ardigen
11.14.1 Ardigen Company Details
11.14.2 Ardigen Business Overview
11.14.3 Ardigen AI-driven Drug Discovery Introduction
11.14.4 Ardigen Revenue in AI-driven Drug Discovery Business (2020-2025)
11.14.5 Ardigen Recent Development
11.15 ReviveMed
11.15.1 ReviveMed Company Details
11.15.2 ReviveMed Business Overview
11.15.3 ReviveMed AI-driven Drug Discovery Introduction
11.15.4 ReviveMed Revenue in AI-driven Drug Discovery Business (2020-2025)
11.15.5 ReviveMed Recent Development
11.16 Insilico Medicine
11.16.1 Insilico Medicine Company Details
11.16.2 Insilico Medicine Business Overview
11.16.3 Insilico Medicine AI-driven Drug Discovery Introduction
11.16.4 Insilico Medicine Revenue in AI-driven Drug Discovery Business (2020-2025)
11.16.5 Insilico Medicine Recent Development
11.17 XtalPi
11.17.1 XtalPi Company Details
11.17.2 XtalPi Business Overview
11.17.3 XtalPi AI-driven Drug Discovery Introduction
11.17.4 XtalPi Revenue in AI-driven Drug Discovery Business (2020-2025)
11.17.5 XtalPi Recent Development
11.18 MindRank
11.18.1 MindRank Company Details
11.18.2 MindRank Business Overview
11.18.3 MindRank AI-driven Drug Discovery Introduction
11.18.4 MindRank Revenue in AI-driven Drug Discovery Business (2020-2025)
11.18.5 MindRank Recent Development
11.19 DP Technology
11.19.1 DP Technology Company Details
11.19.2 DP Technology Business Overview
11.19.3 DP Technology AI-driven Drug Discovery Introduction
11.19.4 DP Technology Revenue in AI-driven Drug Discovery Business (2020-2025)
11.19.5 DP Technology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global AI-driven Drug Discovery Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Small Molecule Drug
Table 3. Key Players of Biological Modeling
Table 4. Key Players of Structural Biology
Table 5. Key Players of Others
Table 6. Global AI-driven Drug Discovery Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global AI-driven Drug Discovery Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global AI-driven Drug Discovery Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global AI-driven Drug Discovery Market Share by Region (2020-2025)
Table 10. Global AI-driven Drug Discovery Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global AI-driven Drug Discovery Market Share by Region (2026-2031)
Table 12. AI-driven Drug Discovery Market Trends
Table 13. AI-driven Drug Discovery Market Drivers
Table 14. AI-driven Drug Discovery Market Challenges
Table 15. AI-driven Drug Discovery Market Restraints
Table 16. Global AI-driven Drug Discovery Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global AI-driven Drug Discovery Market Share by Players (2020-2025)
Table 18. Global Top AI-driven Drug Discovery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI-driven Drug Discovery as of 2024)
Table 19. Ranking of Global Top AI-driven Drug Discovery Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by AI-driven Drug Discovery Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of AI-driven Drug Discovery, Headquarters and Area Served
Table 22. Global Key Players of AI-driven Drug Discovery, Product and Application
Table 23. Global Key Players of AI-driven Drug Discovery, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global AI-driven Drug Discovery Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global AI-driven Drug Discovery Revenue Market Share by Type (2020-2025)
Table 27. Global AI-driven Drug Discovery Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global AI-driven Drug Discovery Revenue Market Share by Type (2026-2031)
Table 29. Global AI-driven Drug Discovery Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global AI-driven Drug Discovery Revenue Market Share by Application (2020-2025)
Table 31. Global AI-driven Drug Discovery Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global AI-driven Drug Discovery Revenue Market Share by Application (2026-2031)
Table 33. North America AI-driven Drug Discovery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America AI-driven Drug Discovery Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America AI-driven Drug Discovery Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe AI-driven Drug Discovery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe AI-driven Drug Discovery Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe AI-driven Drug Discovery Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific AI-driven Drug Discovery Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific AI-driven Drug Discovery Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific AI-driven Drug Discovery Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America AI-driven Drug Discovery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America AI-driven Drug Discovery Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America AI-driven Drug Discovery Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa AI-driven Drug Discovery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa AI-driven Drug Discovery Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa AI-driven Drug Discovery Market Size by Country (2026-2031) & (US$ Million)
Table 48. Entos Company Details
Table 49. Entos Business Overview
Table 50. Entos AI-driven Drug Discovery Product
Table 51. Entos Revenue in AI-driven Drug Discovery Business (2020-2025) & (US$ Million)
Table 52. Entos Recent Development
Table 53. Selvita Company Details
Table 54. Selvita Business Overview
Table 55. Selvita AI-driven Drug Discovery Product
Table 56. Selvita Revenue in AI-driven Drug Discovery Business (2020-2025) & (US$ Million)
Table 57. Selvita Recent Development
Table 58. Benevolent Company Details
Table 59. Benevolent Business Overview
Table 60. Benevolent AI-driven Drug Discovery Product
Table 61. Benevolent Revenue in AI-driven Drug Discovery Business (2020-2025) & (US$ Million)
Table 62. Benevolent Recent Development
Table 63. Exscientia Company Details
Table 64. Exscientia Business Overview
Table 65. Exscientia AI-driven Drug Discovery Product
Table 66. Exscientia Revenue in AI-driven Drug Discovery Business (2020-2025) & (US$ Million)
Table 67. Exscientia Recent Development
Table 68. Euretos Company Details
Table 69. Euretos Business Overview
Table 70. Euretos AI-driven Drug Discovery Product
Table 71. Euretos Revenue in AI-driven Drug Discovery Business (2020-2025) & (US$ Million)
Table 72. Euretos Recent Development
Table 73. Illumina with AstraZeneca Company Details
Table 74. Illumina with AstraZeneca Business Overview
Table 75. Illumina with AstraZeneca AI-driven Drug Discovery Product
Table 76. Illumina with AstraZeneca Revenue in AI-driven Drug Discovery Business (2020-2025) & (US$ Million)
Table 77. Illumina with AstraZeneca Recent Development
Table 78. Novo Nordisk with Microsoft Company Details
Table 79. Novo Nordisk with Microsoft Business Overview
Table 80. Novo Nordisk with Microsoft AI-driven Drug Discovery Product
Table 81. Novo Nordisk with Microsoft Revenue in AI-driven Drug Discovery Business (2020-2025) & (US$ Million)
Table 82. Novo Nordisk with Microsoft Recent Development
Table 83. Iktos Company Details
Table 84. Iktos Business Overview
Table 85. Iktos AI-driven Drug Discovery Product
Table 86. Iktos Revenue in AI-driven Drug Discovery Business (2020-2025) & (US$ Million)
Table 87. Iktos Recent Development
Table 88. Aqemia Company Details
Table 89. Aqemia Business Overview
Table 90. Aqemia AI-driven Drug Discovery Product
Table 91. Aqemia Revenue in AI-driven Drug Discovery Business (2020-2025) & (US$ Million)
Table 92. Aqemia Recent Development
Table 93. Zephyr AI Company Details
Table 94. Zephyr AI Business Overview
Table 95. Zephyr AI AI-driven Drug Discovery Product
Table 96. Zephyr AI Revenue in AI-driven Drug Discovery Business (2020-2025) & (US$ Million)
Table 97. Zephyr AI Recent Development
Table 98. Cyclicarx Company Details
Table 99. Cyclicarx Business Overview
Table 100. Cyclicarx AI-driven Drug Discovery Product
Table 101. Cyclicarx Revenue in AI-driven Drug Discovery Business (2020-2025) & (US$ Million)
Table 102. Cyclicarx Recent Development
Table 103. Eli Lilly Company Details
Table 104. Eli Lilly Business Overview
Table 105. Eli Lilly AI-driven Drug Discovery Product
Table 106. Eli Lilly Revenue in AI-driven Drug Discovery Business (2020-2025) & (US$ Million)
Table 107. Eli Lilly Recent Development
Table 108. Terray Therapeutics Company Details
Table 109. Terray Therapeutics Business Overview
Table 110. Terray Therapeutics AI-driven Drug Discovery Product
Table 111. Terray Therapeutics Revenue in AI-driven Drug Discovery Business (2020-2025) & (US$ Million)
Table 112. Terray Therapeutics Recent Development
Table 113. Ardigen Company Details
Table 114. Ardigen Business Overview
Table 115. Ardigen AI-driven Drug Discovery Product
Table 116. Ardigen Revenue in AI-driven Drug Discovery Business (2020-2025) & (US$ Million)
Table 117. Ardigen Recent Development
Table 118. ReviveMed Company Details
Table 119. ReviveMed Business Overview
Table 120. ReviveMed AI-driven Drug Discovery Product
Table 121. ReviveMed Revenue in AI-driven Drug Discovery Business (2020-2025) & (US$ Million)
Table 122. ReviveMed Recent Development
Table 123. Insilico Medicine Company Details
Table 124. Insilico Medicine Business Overview
Table 125. Insilico Medicine AI-driven Drug Discovery Product
Table 126. Insilico Medicine Revenue in AI-driven Drug Discovery Business (2020-2025) & (US$ Million)
Table 127. Insilico Medicine Recent Development
Table 128. XtalPi Company Details
Table 129. XtalPi Business Overview
Table 130. XtalPi AI-driven Drug Discovery Product
Table 131. XtalPi Revenue in AI-driven Drug Discovery Business (2020-2025) & (US$ Million)
Table 132. XtalPi Recent Development
Table 133. MindRank Company Details
Table 134. MindRank Business Overview
Table 135. MindRank AI-driven Drug Discovery Product
Table 136. MindRank Revenue in AI-driven Drug Discovery Business (2020-2025) & (US$ Million)
Table 137. MindRank Recent Development
Table 138. DP Technology Company Details
Table 139. DP Technology Business Overview
Table 140. DP Technology AI-driven Drug Discovery Product
Table 141. DP Technology Revenue in AI-driven Drug Discovery Business (2020-2025) & (US$ Million)
Table 142. DP Technology Recent Development
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. AI-driven Drug Discovery Picture
Figure 2. Global AI-driven Drug Discovery Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global AI-driven Drug Discovery Market Share by Type: 2024 VS 2031
Figure 4. Small Molecule Drug Features
Figure 5. Biological Modeling Features
Figure 6. Structural Biology Features
Figure 7. Others Features
Figure 8. Global AI-driven Drug Discovery Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global AI-driven Drug Discovery Market Share by Application: 2024 VS 2031
Figure 10. Pharmaceutical and Biotechnology Companies Case Studies
Figure 11. Research Laboratories Case Studies
Figure 12. AI-driven Drug Discovery Report Years Considered
Figure 13. Global AI-driven Drug Discovery Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global AI-driven Drug Discovery Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global AI-driven Drug Discovery Market Share by Region: 2024 VS 2031
Figure 16. Global AI-driven Drug Discovery Market Share by Players in 2024
Figure 17. Global Top AI-driven Drug Discovery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI-driven Drug Discovery as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by AI-driven Drug Discovery Revenue in 2024
Figure 19. North America AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America AI-driven Drug Discovery Market Share by Country (2020-2031)
Figure 21. United States AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe AI-driven Drug Discovery Market Share by Country (2020-2031)
Figure 25. Germany AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific AI-driven Drug Discovery Market Share by Region (2020-2031)
Figure 33. China AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America AI-driven Drug Discovery Market Share by Country (2020-2031)
Figure 41. Mexico AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa AI-driven Drug Discovery Market Share by Country (2020-2031)
Figure 45. Turkey AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Entos Revenue Growth Rate in AI-driven Drug Discovery Business (2020-2025)
Figure 49. Selvita Revenue Growth Rate in AI-driven Drug Discovery Business (2020-2025)
Figure 50. Benevolent Revenue Growth Rate in AI-driven Drug Discovery Business (2020-2025)
Figure 51. Exscientia Revenue Growth Rate in AI-driven Drug Discovery Business (2020-2025)
Figure 52. Euretos Revenue Growth Rate in AI-driven Drug Discovery Business (2020-2025)
Figure 53. Illumina with AstraZeneca Revenue Growth Rate in AI-driven Drug Discovery Business (2020-2025)
Figure 54. Novo Nordisk with Microsoft Revenue Growth Rate in AI-driven Drug Discovery Business (2020-2025)
Figure 55. Iktos Revenue Growth Rate in AI-driven Drug Discovery Business (2020-2025)
Figure 56. Aqemia Revenue Growth Rate in AI-driven Drug Discovery Business (2020-2025)
Figure 57. Zephyr AI Revenue Growth Rate in AI-driven Drug Discovery Business (2020-2025)
Figure 58. Cyclicarx Revenue Growth Rate in AI-driven Drug Discovery Business (2020-2025)
Figure 59. Eli Lilly Revenue Growth Rate in AI-driven Drug Discovery Business (2020-2025)
Figure 60. Terray Therapeutics Revenue Growth Rate in AI-driven Drug Discovery Business (2020-2025)
Figure 61. Ardigen Revenue Growth Rate in AI-driven Drug Discovery Business (2020-2025)
Figure 62. ReviveMed Revenue Growth Rate in AI-driven Drug Discovery Business (2020-2025)
Figure 63. Insilico Medicine Revenue Growth Rate in AI-driven Drug Discovery Business (2020-2025)
Figure 64. XtalPi Revenue Growth Rate in AI-driven Drug Discovery Business (2020-2025)
Figure 65. MindRank Revenue Growth Rate in AI-driven Drug Discovery Business (2020-2025)
Figure 66. DP Technology Revenue Growth Rate in AI-driven Drug Discovery Business (2020-2025)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Table 1. Global AI-driven Drug Discovery Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Small Molecule Drug
Table 3. Key Players of Biological Modeling
Table 4. Key Players of Structural Biology
Table 5. Key Players of Others
Table 6. Global AI-driven Drug Discovery Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global AI-driven Drug Discovery Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global AI-driven Drug Discovery Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global AI-driven Drug Discovery Market Share by Region (2020-2025)
Table 10. Global AI-driven Drug Discovery Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global AI-driven Drug Discovery Market Share by Region (2026-2031)
Table 12. AI-driven Drug Discovery Market Trends
Table 13. AI-driven Drug Discovery Market Drivers
Table 14. AI-driven Drug Discovery Market Challenges
Table 15. AI-driven Drug Discovery Market Restraints
Table 16. Global AI-driven Drug Discovery Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global AI-driven Drug Discovery Market Share by Players (2020-2025)
Table 18. Global Top AI-driven Drug Discovery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI-driven Drug Discovery as of 2024)
Table 19. Ranking of Global Top AI-driven Drug Discovery Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by AI-driven Drug Discovery Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of AI-driven Drug Discovery, Headquarters and Area Served
Table 22. Global Key Players of AI-driven Drug Discovery, Product and Application
Table 23. Global Key Players of AI-driven Drug Discovery, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global AI-driven Drug Discovery Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global AI-driven Drug Discovery Revenue Market Share by Type (2020-2025)
Table 27. Global AI-driven Drug Discovery Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global AI-driven Drug Discovery Revenue Market Share by Type (2026-2031)
Table 29. Global AI-driven Drug Discovery Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global AI-driven Drug Discovery Revenue Market Share by Application (2020-2025)
Table 31. Global AI-driven Drug Discovery Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global AI-driven Drug Discovery Revenue Market Share by Application (2026-2031)
Table 33. North America AI-driven Drug Discovery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America AI-driven Drug Discovery Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America AI-driven Drug Discovery Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe AI-driven Drug Discovery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe AI-driven Drug Discovery Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe AI-driven Drug Discovery Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific AI-driven Drug Discovery Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific AI-driven Drug Discovery Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific AI-driven Drug Discovery Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America AI-driven Drug Discovery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America AI-driven Drug Discovery Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America AI-driven Drug Discovery Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa AI-driven Drug Discovery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa AI-driven Drug Discovery Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa AI-driven Drug Discovery Market Size by Country (2026-2031) & (US$ Million)
Table 48. Entos Company Details
Table 49. Entos Business Overview
Table 50. Entos AI-driven Drug Discovery Product
Table 51. Entos Revenue in AI-driven Drug Discovery Business (2020-2025) & (US$ Million)
Table 52. Entos Recent Development
Table 53. Selvita Company Details
Table 54. Selvita Business Overview
Table 55. Selvita AI-driven Drug Discovery Product
Table 56. Selvita Revenue in AI-driven Drug Discovery Business (2020-2025) & (US$ Million)
Table 57. Selvita Recent Development
Table 58. Benevolent Company Details
Table 59. Benevolent Business Overview
Table 60. Benevolent AI-driven Drug Discovery Product
Table 61. Benevolent Revenue in AI-driven Drug Discovery Business (2020-2025) & (US$ Million)
Table 62. Benevolent Recent Development
Table 63. Exscientia Company Details
Table 64. Exscientia Business Overview
Table 65. Exscientia AI-driven Drug Discovery Product
Table 66. Exscientia Revenue in AI-driven Drug Discovery Business (2020-2025) & (US$ Million)
Table 67. Exscientia Recent Development
Table 68. Euretos Company Details
Table 69. Euretos Business Overview
Table 70. Euretos AI-driven Drug Discovery Product
Table 71. Euretos Revenue in AI-driven Drug Discovery Business (2020-2025) & (US$ Million)
Table 72. Euretos Recent Development
Table 73. Illumina with AstraZeneca Company Details
Table 74. Illumina with AstraZeneca Business Overview
Table 75. Illumina with AstraZeneca AI-driven Drug Discovery Product
Table 76. Illumina with AstraZeneca Revenue in AI-driven Drug Discovery Business (2020-2025) & (US$ Million)
Table 77. Illumina with AstraZeneca Recent Development
Table 78. Novo Nordisk with Microsoft Company Details
Table 79. Novo Nordisk with Microsoft Business Overview
Table 80. Novo Nordisk with Microsoft AI-driven Drug Discovery Product
Table 81. Novo Nordisk with Microsoft Revenue in AI-driven Drug Discovery Business (2020-2025) & (US$ Million)
Table 82. Novo Nordisk with Microsoft Recent Development
Table 83. Iktos Company Details
Table 84. Iktos Business Overview
Table 85. Iktos AI-driven Drug Discovery Product
Table 86. Iktos Revenue in AI-driven Drug Discovery Business (2020-2025) & (US$ Million)
Table 87. Iktos Recent Development
Table 88. Aqemia Company Details
Table 89. Aqemia Business Overview
Table 90. Aqemia AI-driven Drug Discovery Product
Table 91. Aqemia Revenue in AI-driven Drug Discovery Business (2020-2025) & (US$ Million)
Table 92. Aqemia Recent Development
Table 93. Zephyr AI Company Details
Table 94. Zephyr AI Business Overview
Table 95. Zephyr AI AI-driven Drug Discovery Product
Table 96. Zephyr AI Revenue in AI-driven Drug Discovery Business (2020-2025) & (US$ Million)
Table 97. Zephyr AI Recent Development
Table 98. Cyclicarx Company Details
Table 99. Cyclicarx Business Overview
Table 100. Cyclicarx AI-driven Drug Discovery Product
Table 101. Cyclicarx Revenue in AI-driven Drug Discovery Business (2020-2025) & (US$ Million)
Table 102. Cyclicarx Recent Development
Table 103. Eli Lilly Company Details
Table 104. Eli Lilly Business Overview
Table 105. Eli Lilly AI-driven Drug Discovery Product
Table 106. Eli Lilly Revenue in AI-driven Drug Discovery Business (2020-2025) & (US$ Million)
Table 107. Eli Lilly Recent Development
Table 108. Terray Therapeutics Company Details
Table 109. Terray Therapeutics Business Overview
Table 110. Terray Therapeutics AI-driven Drug Discovery Product
Table 111. Terray Therapeutics Revenue in AI-driven Drug Discovery Business (2020-2025) & (US$ Million)
Table 112. Terray Therapeutics Recent Development
Table 113. Ardigen Company Details
Table 114. Ardigen Business Overview
Table 115. Ardigen AI-driven Drug Discovery Product
Table 116. Ardigen Revenue in AI-driven Drug Discovery Business (2020-2025) & (US$ Million)
Table 117. Ardigen Recent Development
Table 118. ReviveMed Company Details
Table 119. ReviveMed Business Overview
Table 120. ReviveMed AI-driven Drug Discovery Product
Table 121. ReviveMed Revenue in AI-driven Drug Discovery Business (2020-2025) & (US$ Million)
Table 122. ReviveMed Recent Development
Table 123. Insilico Medicine Company Details
Table 124. Insilico Medicine Business Overview
Table 125. Insilico Medicine AI-driven Drug Discovery Product
Table 126. Insilico Medicine Revenue in AI-driven Drug Discovery Business (2020-2025) & (US$ Million)
Table 127. Insilico Medicine Recent Development
Table 128. XtalPi Company Details
Table 129. XtalPi Business Overview
Table 130. XtalPi AI-driven Drug Discovery Product
Table 131. XtalPi Revenue in AI-driven Drug Discovery Business (2020-2025) & (US$ Million)
Table 132. XtalPi Recent Development
Table 133. MindRank Company Details
Table 134. MindRank Business Overview
Table 135. MindRank AI-driven Drug Discovery Product
Table 136. MindRank Revenue in AI-driven Drug Discovery Business (2020-2025) & (US$ Million)
Table 137. MindRank Recent Development
Table 138. DP Technology Company Details
Table 139. DP Technology Business Overview
Table 140. DP Technology AI-driven Drug Discovery Product
Table 141. DP Technology Revenue in AI-driven Drug Discovery Business (2020-2025) & (US$ Million)
Table 142. DP Technology Recent Development
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. AI-driven Drug Discovery Picture
Figure 2. Global AI-driven Drug Discovery Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global AI-driven Drug Discovery Market Share by Type: 2024 VS 2031
Figure 4. Small Molecule Drug Features
Figure 5. Biological Modeling Features
Figure 6. Structural Biology Features
Figure 7. Others Features
Figure 8. Global AI-driven Drug Discovery Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global AI-driven Drug Discovery Market Share by Application: 2024 VS 2031
Figure 10. Pharmaceutical and Biotechnology Companies Case Studies
Figure 11. Research Laboratories Case Studies
Figure 12. AI-driven Drug Discovery Report Years Considered
Figure 13. Global AI-driven Drug Discovery Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global AI-driven Drug Discovery Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global AI-driven Drug Discovery Market Share by Region: 2024 VS 2031
Figure 16. Global AI-driven Drug Discovery Market Share by Players in 2024
Figure 17. Global Top AI-driven Drug Discovery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI-driven Drug Discovery as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by AI-driven Drug Discovery Revenue in 2024
Figure 19. North America AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America AI-driven Drug Discovery Market Share by Country (2020-2031)
Figure 21. United States AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe AI-driven Drug Discovery Market Share by Country (2020-2031)
Figure 25. Germany AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific AI-driven Drug Discovery Market Share by Region (2020-2031)
Figure 33. China AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America AI-driven Drug Discovery Market Share by Country (2020-2031)
Figure 41. Mexico AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa AI-driven Drug Discovery Market Share by Country (2020-2031)
Figure 45. Turkey AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE AI-driven Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Entos Revenue Growth Rate in AI-driven Drug Discovery Business (2020-2025)
Figure 49. Selvita Revenue Growth Rate in AI-driven Drug Discovery Business (2020-2025)
Figure 50. Benevolent Revenue Growth Rate in AI-driven Drug Discovery Business (2020-2025)
Figure 51. Exscientia Revenue Growth Rate in AI-driven Drug Discovery Business (2020-2025)
Figure 52. Euretos Revenue Growth Rate in AI-driven Drug Discovery Business (2020-2025)
Figure 53. Illumina with AstraZeneca Revenue Growth Rate in AI-driven Drug Discovery Business (2020-2025)
Figure 54. Novo Nordisk with Microsoft Revenue Growth Rate in AI-driven Drug Discovery Business (2020-2025)
Figure 55. Iktos Revenue Growth Rate in AI-driven Drug Discovery Business (2020-2025)
Figure 56. Aqemia Revenue Growth Rate in AI-driven Drug Discovery Business (2020-2025)
Figure 57. Zephyr AI Revenue Growth Rate in AI-driven Drug Discovery Business (2020-2025)
Figure 58. Cyclicarx Revenue Growth Rate in AI-driven Drug Discovery Business (2020-2025)
Figure 59. Eli Lilly Revenue Growth Rate in AI-driven Drug Discovery Business (2020-2025)
Figure 60. Terray Therapeutics Revenue Growth Rate in AI-driven Drug Discovery Business (2020-2025)
Figure 61. Ardigen Revenue Growth Rate in AI-driven Drug Discovery Business (2020-2025)
Figure 62. ReviveMed Revenue Growth Rate in AI-driven Drug Discovery Business (2020-2025)
Figure 63. Insilico Medicine Revenue Growth Rate in AI-driven Drug Discovery Business (2020-2025)
Figure 64. XtalPi Revenue Growth Rate in AI-driven Drug Discovery Business (2020-2025)
Figure 65. MindRank Revenue Growth Rate in AI-driven Drug Discovery Business (2020-2025)
Figure 66. DP Technology Revenue Growth Rate in AI-driven Drug Discovery Business (2020-2025)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232